[1]李冰涛,章辉,肖思雨,等.基于网络药理学的葛根治疗冠心病作用机制研究[J].中国中医药信息杂志,2019,26(10):96-100.[doi:10.3969/j.issn.1005-5304.2019.10.021]
 LI Bingtao,ZHANG Hui,XIAO Siyu,et al.Study on Mechanism of Puerariae Lobatae Radix in Treating Coronary Heart Disease Based on Network Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2019,26(10):96-100.[doi:10.3969/j.issn.1005-5304.2019.10.021]
点击复制

基于网络药理学的葛根治疗冠心病作用机制研究

参考文献/References:

[1] 王永刚,齐婧,钟伟,等.冠心病中医病因病机的认识与探索[J].中医杂志,2015,56(17):1449-1452.

[2] 张苒,石磊.《金匮要略》“阳微阴弦”在冠心病心绞痛辨治中的指导意义[J].现代中西医结合杂志,2009,18(27):3288-3289.

[3] 国家药典委员会.中华人民共和国药典:一部[M].北京:中国医药科技出版社,2015:333.

[4] LIPINSKI C A, LOMBARDO F, DOMINY B W, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1[J]. Advanced Drug Delivery Reviews,2012,64(1/2/3):4-17.

[5] 潘国凤,罗然,吕文英,等.基于网络药理学养阴清肺口服液对肺损伤的保护作用及机制研究[J].中药药理与临床,2018,34(1):19-24.

[6] 刘培,肖隋熙,罗颖,等.心血瘀阻证动态演变过程生物信息学研究[J].湖南中医药大学学报,2018,38(2):130-135.

[7] 杨鲁渤,李光明,张庆成,等.冠心病患者血浆花生四烯酸代谢产物的临床研究[J].医学综述,1997,3(11):542-543.

[8] 乔爱敏,李乐,刘青.晚期糖基化终产物及其受体RAGE在糖尿病血管并发症中的作用机制[J].中国临床药理学与治疗学,2014,19(11):1306- 1311.

[9] KIM J M, LEE Y M, LEE G Y, et al. Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs)[J]. Archives of Pharmacal Research,2006,29(10)821-825.

[10] 徐波,张玲.葛根素对冠心病患者血浆内皮素和一氧化氮水平及心肌缺血的疗效探讨[J].实用临床医药杂志,2012,16(17):37-39.

[11] 曾跃华,陈云龙.葛根素治疗冠心病及对活化血小板的影响[J].长春中医药大学学报,2011,27(6):997.

相似文献/References:

[1]刘雪涛,叶祖光.冠心病心肌缺血的中医治法方药研究概述[J].中国中医药信息杂志,2010,17(5):106.
[2]赵华云,王文会,郎江明,等.参七汤干预冠心病支架植入术后再狭窄临床研究[J].中国中医药信息杂志,2010,17(2):18.
 ZHAO Hua-yun,WANG Wen-hui,LANG Jiang-ming,et al.Clinical Study of Shenqi Decoction in Treating Restenosis after Implantation of Stents in Patients with Coronary Artery Disease[J].zhongguo zhongyiyao xinxi zazhi,2010,17(10):18.
[3]姚欣艳,谭元生,高晓峰,等.十味温胆汤加味治疗冠心病稳定型心绞痛气虚痰瘀证临床研究[J].中国中医药信息杂志,2009,16(1):15.
 YAO Xin-yan,TAN Yuan-sheng,GAO Xiao-feng,et al.Clinical Study of Shiwei Wendan Decoction in Treating Coronary Heart Disease Stable Angina Pectoris of Qi Deficiency and Stasis-phlegm Type[J].zhongguo zhongyiyao xinxi zazhi,2009,16(10):15.
[4]康兴霞,范平.怡心汤治疗冠心病心绞痛疗效观察[J].中国中医药信息杂志,2010,17(7):5.[doi:10.3969/j.issn.1005-5304.2010.07.003]
 KANG Xing-xia,FAN Ping.Clinical Observation of Yixin Tang in Treating Angina Pectoris of Coronary Heart Disease[J].zhongguo zhongyiyao xinxi zazhi,2010,17(10):5.[doi:10.3969/j.issn.1005-5304.2010.07.003]
[5]郎立和.补阳还五汤临证举隅[J].中国中医药信息杂志,2010,17(7):88.[doi:10.3969/j.issn.1005-5304.2010.07.044]
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(10):88.[doi:10.3969/j.issn.1005-5304.2010.07.044]
[6]颜乾麟.颜德馨审机论治冠心病经验[J].中国中医药信息杂志,2009,16(2):88.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(10):88.
[7]张玉辉.曹洪欣治疗疑难病证5则[J].中国中医药信息杂志,2009,16(3):77.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(10):77.
[8]倪青,闫秀峰,林兰.芪蛭降糖胶囊治疗2型糖尿病合并冠心病心绞痛128例临床观察[J].中国中医药信息杂志,2010,17(10):9.[doi:10.3969/j.issn.1005-5304.2010.10.005]
 NI Qing,YAN Xiu-feng,LIN Lan.Clinical Study on the Effect of Qizhi Jiangtang Capsule in Treating 128 Patients with Diabetic Coronary Heart Disease and Angina[J].zhongguo zhongyiyao xinxi zazhi,2010,17(10):9.[doi:10.3969/j.issn.1005-5304.2010.10.005]
[9]张明雪,曹洪欣,林巾孝,等.冠心病临床专家调查问卷信度效度分析[J].中国中医药信息杂志,2009,16(4):18.
 ZHANG Ming-xue,CAO Hong-xin,LIN Jin-xiao,et al.Analysis of Reliability and Validity for Clinical Experts Questionnaire about Coronary Heart Disease[J].zhongguo zhongyiyao xinxi zazhi,2009,16(10):18.
[10]严洁,刁利红,常小荣,等.电针、复方丹参滴丸、针药结合对冠心病患者心肌耗氧量和临床症状积分的对照研究[J].中国中医药信息杂志,2007,14(2):14.
 YAN Jie,DIAO Li-hong,CHANG Xiao-rong,et al.Control Study of Three Different Treatment Method on MCO and ICS in Coronary Artery Disease[J].zhongguo zhongyiyao xinxi zazhi,2007,14(10):14.

备注/Memo

基金项目:国家重点研发计划(2017YF1702902);江西中医药大学博士启动基金(2015BS010)

更新日期/Last Update:

2019-09-18